DRKS00015528已完成不适用
CNS-reactive B cells in the blood are biomarkers for therapeutic responsiveness and disease activity in Lemtrada-treated MS patients
Institut für Anatomie und ZellbiologieFAU Erlangen-Nürnberg0 个研究点目标入组 30 人开始时间: 2018年9月14日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 Years 至 65 Years（—）
- 性别
- All
入选标准
- •RRMS, treatment with Lemtrada (Alemtuzumab)
排除标准
- •Lack of compliance
研究者
相似试验
招募中
不适用
Measurements of CNS-reactive B cells and their specificity in the blood of ocrelizumab-treated patientsMultiple sclerosisG35DRKS00029110Institut für Neuroanatomie, Universitätsklinikum Bonn64
招募中
Unknown
Biomarkers of Neurological Diseases and iPS Cell-Based Disease Researcheurological DiseasesJPRN-UMIN000052395keio university1,000
已完成
Unknown
Biomarkers of Neurological Diseases and iPS Cell-Based Disease Researcheurological DiseasesJPRN-UMIN000052697Keio University
招募中
不适用
Berlin Registry of Neuroimmunological EntitiesICD-11Codes: 8A40.08A40.28A40.18A40.Y8A40.Z8A41.18A41.08A41.Z8A43.08A43.18A43.Z8A45.28E489C40.1ZDRKS00026761Charité - Universitätsmedizin Berlin, Experimental and Clinical Research Center (ECRC) AG Klinische Neuroimmunologie735
已完成
不适用
B cell signalling differences in acute cellular rejection after lung transplantation (HAMLET)NL-OMON49616Erasmus MC, Universitair Medisch Centrum Rotterdam30